180 Life Sciences (NASDAQ:ATNF) closed the recruitment of people with early stage Frozen shoulder in a trial in England after a government agency noted that the study was facing challenges. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback